LINAGLIPTIN vs TRADJENTA
Independent side-by-side comparison.
Rating
New
72/100
Pharmacy pays
—
—
Type
RX
RX
Active ingredient
LINAGLIPTIN
LINAGLIPTIN
Manufacturer
Dosage forms
Tablet
Tablet
Drug class
Dipeptidyl Peptidase 4 Inhibitor
Dipeptidyl Peptidase 4 Inhibitor
Boxed warning
None
None
Half-life
about 200 hours — the terminal (elimination) half-life at steady state, per the label
about 200 hours — the terminal (elimination) half-life at steady state, per the label
Treats
Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus
Get tradjentahigher-rated option
Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.
Get treatment online
Licensed online providers — consult & get prescribed if eligible.
Frequently asked questions
What is the difference between Linagliptin and Tradjenta?
Both Linagliptin and Tradjenta share the active ingredient Linagliptin.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.